7 minute Hepatology

Join Dr Richard Skoien and Dr Alison Kearney as we discuss the Hepatocare model and the importance of appropriate and timely palliative care referral. Scottish Guidelines: https://www.palliativecareguidelines.scot.nhs.uk/scottish-palliative-care-guidelines/last-days-of-life-care-around-dying/end-stage-liver-disease/

Join A/Prof Juan Pablo Arab as we discuss using steroids in alcohol associated hepatitis. Arab JP, Díaz LA, Baeza N, Idalsoaga F, Fuentes-López E, Arnold J, Ramírez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, García-Carrera I, Parker R, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladaný L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincón D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, García-Tsao G, González JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. J Hepatol. 2021 Nov;75(5):1026-1033. doi: 10.1016/j.jhep.2021.06.019. Epub 2021 Jun 21. PMID: 34166722; PMCID: PMC11090180.https://pubmed.ncbi.nlm.nih.gov/34166722/

Join A/Prof Juan Pablo Arab as we discuss what is Met-ALD. Article: https://www.journal-of-hepatology.eu/article/S0168-8278(24)02728-4/pdf

Join Dr Vaitiekunas as he interviews Prof Abraldes answering all the important questions regarding beta blockers in cirrhosis.Further reading: Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysishttps://www.sciencedirect.com/science/article/abs/pii/S0168827825025656

nterested in one of the most unique and trainee focussed hepatology fellowships in Australia? Watch below ⬇️ ⬇️ ⬇️ Opportunity to tailor your experience in:1. Dedicated HCC clinic including prescribing immunotherapy with incorporated clinical trials 2. Specialised clinics in PBC and PSC-IBD3. Options to have specialised clinics in complex portal hypertension/advanced hepatology/MASLD/ARLD4. Dedicated experience as "consultant on the ward" 5. Portal hypertension endoscopy lists6. Be part of multiple investigator and the latest phase 3 trials 7. International collaborations 8. Learn from experts in clinical, research and public healthJoin us at the Sunshine Coast. What are you waiting for? To apply: https://lnkd.in/gG9dy_GFDeadline: 16th June